DD144168A5 - Verfahren zur herstellung von 17-hydroxyspartein - Google Patents
Verfahren zur herstellung von 17-hydroxyspartein Download PDFInfo
- Publication number
- DD144168A5 DD144168A5 DD79213406A DD21340679A DD144168A5 DD 144168 A5 DD144168 A5 DD 144168A5 DD 79213406 A DD79213406 A DD 79213406A DD 21340679 A DD21340679 A DD 21340679A DD 144168 A5 DD144168 A5 DD 144168A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- oxidation
- permanganate
- solution
- items
- preparation
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 title claims description 19
- 230000003647 oxidation Effects 0.000 claims abstract description 19
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 19
- 229960001945 sparteine Drugs 0.000 claims abstract description 13
- SLRCCWJSBJZJBV-AJNGGQMLSA-N sparteine Chemical compound C1N2CCCC[C@H]2[C@@H]2CN3CCCC[C@H]3[C@H]1C2 SLRCCWJSBJZJBV-AJNGGQMLSA-N 0.000 claims abstract description 11
- SLRCCWJSBJZJBV-UHFFFAOYSA-N alpha-isosparteine Natural products C1N2CCCCC2C2CN3CCCCC3C1C2 SLRCCWJSBJZJBV-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229930008564 C01BA04 - Sparteine Natural products 0.000 claims abstract description 6
- JLUGKDWGQPNDGX-UHFFFAOYSA-L azanium;manganese(2+);phosphate Chemical compound [NH4+].[Mn+2].[O-]P([O-])([O-])=O JLUGKDWGQPNDGX-UHFFFAOYSA-L 0.000 claims abstract description 5
- 239000011541 reaction mixture Substances 0.000 claims abstract description 5
- 239000003929 acidic solution Substances 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 14
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- 101000588924 Anthopleura elegantissima Delta-actitoxin-Ael1a Proteins 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000011572 manganese Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 8
- 239000007800 oxidant agent Substances 0.000 abstract description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- SLRCCWJSBJZJBV-LXTVHRRPSA-N (-)-Spartein Natural products C1N2CCCC[C@@H]2[C@H]2CN3CCCC[C@@H]3[C@H]1C2 SLRCCWJSBJZJBV-LXTVHRRPSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 2
- JGJLWPGRMCADHB-UHFFFAOYSA-N hypobromite Chemical compound Br[O-] JGJLWPGRMCADHB-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- -1 Sparteinsulfat pentahydrate Chemical class 0.000 description 1
- WRYNUJYAXVDTCB-UHFFFAOYSA-M acetyloxymercury Chemical compound CC(=O)O[Hg] WRYNUJYAXVDTCB-UHFFFAOYSA-M 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical class [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 description 1
- 150000001844 chromium Chemical class 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 150000001845 chromium compounds Chemical class 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- BYGOPQKDHGXNCD-UHFFFAOYSA-N tripotassium;iron(3+);hexacyanide Chemical compound [K+].[K+].[K+].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] BYGOPQKDHGXNCD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2825117A DE2825117C2 (de) | 1978-06-08 | 1978-06-08 | Verfahren zur Herstellung von 17-Hydroxyspartein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD144168A5 true DD144168A5 (de) | 1980-10-01 |
Family
ID=6041322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD79213406A DD144168A5 (de) | 1978-06-08 | 1979-06-05 | Verfahren zur herstellung von 17-hydroxyspartein |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4237295A (ru) |
| EP (1) | EP0006151B1 (ru) |
| JP (1) | JPS54160399A (ru) |
| AT (1) | ATE117T1 (ru) |
| CS (1) | CS207307B2 (ru) |
| DD (1) | DD144168A5 (ru) |
| DE (2) | DE2825117C2 (ru) |
| ES (1) | ES480878A1 (ru) |
| HU (1) | HU178021B (ru) |
| PL (1) | PL115724B1 (ru) |
| SU (1) | SU878198A3 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9608152A (pt) * | 1995-04-20 | 1999-02-09 | Robert Glenn Beale | Recipiente com alça integral pré-forma e processo de fabricação |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2360475C3 (de) * | 1973-12-05 | 1980-11-20 | Kali-Chemie Pharma Gmbh, 3000 Hannover | arzneimittel zur Behandlung von Herzrhytmusstörungen |
-
1978
- 1978-06-08 DE DE2825117A patent/DE2825117C2/de not_active Expired
-
1979
- 1979-05-24 ES ES480878A patent/ES480878A1/es not_active Expired
- 1979-05-28 EP EP79101624A patent/EP0006151B1/de not_active Expired
- 1979-05-28 AT AT79101624T patent/ATE117T1/de not_active IP Right Cessation
- 1979-05-28 DE DE7979101624T patent/DE2960508D1/de not_active Expired
- 1979-05-30 HU HU79KA1523A patent/HU178021B/hu not_active IP Right Cessation
- 1979-06-01 US US06/044,693 patent/US4237295A/en not_active Expired - Lifetime
- 1979-06-05 DD DD79213406A patent/DD144168A5/de unknown
- 1979-06-06 CS CS793905A patent/CS207307B2/cs unknown
- 1979-06-07 JP JP7068079A patent/JPS54160399A/ja active Granted
- 1979-06-07 PL PL1979216154A patent/PL115724B1/pl unknown
- 1979-06-08 SU SU792776151A patent/SU878198A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| HU178021B (en) | 1982-02-28 |
| US4237295A (en) | 1980-12-02 |
| DE2825117A1 (de) | 1979-12-13 |
| JPS54160399A (en) | 1979-12-19 |
| ATE117T1 (de) | 1981-08-15 |
| DE2825117C2 (de) | 1982-09-16 |
| CS207307B2 (en) | 1981-07-31 |
| EP0006151A1 (de) | 1980-01-09 |
| ES480878A1 (es) | 1979-11-16 |
| PL115724B1 (en) | 1981-04-30 |
| JPS625436B2 (ru) | 1987-02-04 |
| PL216154A1 (ru) | 1980-03-24 |
| EP0006151B1 (de) | 1981-07-22 |
| SU878198A3 (ru) | 1981-10-30 |
| DE2960508D1 (en) | 1981-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1445506C3 (de) | Verfahren zur Gewinnung von reinem a-Aminobenzylpenicillin | |
| DE3819045C2 (de) | Herstellung von L-Ascorbinsäure | |
| DE3000986A1 (de) | Ferrisalz von fructose-1,6-diphosphat, verfahren zu seiner herstellung und zu seiner verwendung bei der herstellung von fructose-1,6-diphosphorsaeure | |
| DD144168A5 (de) | Verfahren zur herstellung von 17-hydroxyspartein | |
| EP0149857B1 (de) | Verfahren zur Herstellung von Chinolinsäure aus Chinolin | |
| EP1558557B1 (de) | Verfahren zur katalytischen oxidation von methan zu methanol über methanolester | |
| DD146945A5 (de) | Verfahren zur herstellung von 3,3-dimethyl-2-oxobuttersaeure | |
| DE2552159C3 (de) | Verfahren zur Herstellung von PeniciUinestersulfoxiden | |
| DE2745783B2 (de) | Herstellung von Nitroguanidin aus Guanidinnitrat unter Einwirkung von wäßriger Schwefelsäure | |
| DE2745415C2 (de) | Verfahren zur Herstellung von (-)-Vincamin | |
| DE2108455C3 (de) | Verfahren zur Herstellung von gegebenenfalls am aromatischen Ring substituierten Iminodlbenzylen | |
| DE1770603A1 (de) | Verfahren zur Herstellung von 3-Formylrifamycin-SV | |
| DE221849C (ru) | ||
| DE2515084A1 (de) | Verfahren zur herstellung von mono- o-beta-hydroxyaethyl-7 rutin | |
| EP0094560B1 (de) | Verfahren zur Herstellung von 3-(10,11-Dihydro-5H-dibenzo /a,d/-cyclohepten-5-yliden)-N,N-dimethyl-1-propanamin-N-oxid-Dihydrat | |
| DE1568924C (de) | Ketale des Proscillaridins und Verfahren zu deren Herstellung | |
| AT380258B (de) | Verfahren zur herstellung von natrium-ampicillin | |
| AT223327B (de) | Verfahren zur Extraktion von 6-Aminopenicillansäure | |
| DE954285C (de) | Verfahren zur Herstellung von stabilen und weitgehend wasserloeslichen Fumagillinprodukten | |
| DE2931776C2 (de) | Verfahren zur Abtrennung von Citronensäure aus einem Gemisch mit Oxalsäure | |
| DE920791C (de) | Verfahren zur Darstellung von Arylthiosulfonsaeure-S-aryl-estern (Diaryldisulfoxyden) | |
| AT317219B (de) | Verfahren zur Herstellung neuer 4-Phenyl-2(1H)-chinazolinone | |
| DE2006896C3 (de) | Verfahren zur Herstellung von Diäthylaminoäthyl-p-nitrobenzoat | |
| DE1468443C (de) | Verfahren zur Herstellung von 16 alpha, 17 alpha-Dihydroxysteroiden der Pregnanreihe | |
| CH407082A (de) | Verfahren zur gleichzeitigen Herstellung von Adipinsäure und Nitrozyklohexan aus Zyklohexan |